Marker Therapeutics Inc (NASDAQ: MRKR) kicked off on Monday, up 13.10% from the previous trading day, before settling in for the closing price of $0.95. Over the past 52 weeks, MRKR has traded in a range of $0.81-$5.95.
Healthcare Sector giant saw their annual sales surged by 23.96% over the last five years. While this was happening, its average annual earnings per share was recorded -26.05%. With a float of $9.20 million, this company’s outstanding shares have now reached $11.31 million.
The firm has a total of 5 workers. Let’s measure their productivity.
Marker Therapeutics Inc (MRKR) Insider Activity
Our next focus will be how large-scale investors are participating in this stock of the Biotechnology Industry. The insider ownership of Marker Therapeutics Inc is 28.91%, while institutional ownership is 9.82%. The most recent insider transaction that took place on Dec 23 ’24, was worth 35,472. In this transaction Director of this company bought 11,085 shares at a rate of $3.20, taking the stock ownership to the 325,370 shares. Before that another transaction happened on Dec 23 ’24, when Company’s 10% Owner bought 554,250 for $3.20, making the entire transaction worth $1,773,600. This insider now owns 1,625,678 shares in total.
Marker Therapeutics Inc (MRKR) Earnings and Forecasts
In the latest quarterly report, which was put into the public domain on 9/30/2024, the organization reported -0.26 earnings per share (EPS), higher than consensus estimate (set at -0.39) by 0.13. Wall Street market experts anticipate that the next fiscal year will bring earnings of -0.21 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around -26.05% per share during the next fiscal year. For the long-term projections, market analysts anticipate that the company’s EPS will surge by 7.89% during the next five years compared to 23.96% growth over the previous five years of trading.
Marker Therapeutics Inc (NASDAQ: MRKR) Trading Performance Indicators
Take a look at Marker Therapeutics Inc’s (MRKR) current performance indicators. Last quarter, stock had a quick ratio of 3.45. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 2.59.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -1.37, a number that is poised to hit -0.36 in the next quarter and is forecasted to reach -1.74 in one year’s time.
Technical Analysis of Marker Therapeutics Inc (MRKR)
Analysing the last 5-days average volume posted by the [Marker Therapeutics Inc, MRKR], we can find that recorded value of 0.41 million was lower than the volume posted last year of 0.76 million. As of the previous 9 days, the stock’s Stochastic %D was 74.89%.
During the past 100 days, Marker Therapeutics Inc’s (MRKR) raw stochastic average was set at 8.29%, which indicates a significant decrease from 97.87% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 0.0649 in the past 14 days, which was lower than the 0.1375 volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $1.0711, while its 200-day Moving Average is $1.5443. Now, the first resistance to watch is $1.1209. This is followed by the second major resistance level at $1.1619. The third major resistance level sits at $1.2387. If the price goes on to break the first support level at $1.0031, it is likely to go to the next support level at $0.9263. Should the price break the second support level, the third support level stands at $0.8853.
Marker Therapeutics Inc (NASDAQ: MRKR) Key Stats
The company with the Market Capitalisation of 13.97 million has total of 12,939K Shares Outstanding. Its annual sales at the moment are 6,590 K in contrast with the sum of -10,730 K annual income. Company’s last quarter sales were recorded 860 K and last quarter income was -4,020 K.
